{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:20:58Z","timestamp":1767795658474,"version":"3.49.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,6,21]],"date-time":"2006-06-21T00:00:00Z","timestamp":1150848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmic Physiologic Optic"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent changes in UK law have allowed UK\u2010based optometrists to sell and supply fusidic acid viscous eyedrops, providing it is in the course of their professional activity and in an emergency. Alternatively, the optometrist may access fusidic acid viscous eyedrops, for a named patient, using a written order supplied to a pharmacy. This review provides details of the legal background to these changes, examines the common causes of a bacterial conjunctivitis, examines the mechanism of action of this narrow spectrum antibiotic as a bacteriostatic agent, reviews the susceptibility of common ocular isolates of bacteria to the drug and presents details of the expected pharmacokinetics of the viscous eyedrops. From this perspective, a systematic review is provided of the clinical studies which have investigated the use of fusidic acid viscous eyedrops and their outcome. The indicated use is generally for the treatment of bacterial conjunctivitis and\/or blepharoconjunctivitis, especially that caused by\n                    <jats:italic>Staphylococcus<\/jats:italic>\n                    , but not\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    or\n                    <jats:italic>Haemophilus<\/jats:italic>\n                    sp. (more likely associated with concurrent nasopharyngeal infections). The usual regimen for use is twice daily for 5\u201310\u2003days, depending on severity, and can initially be used more intensively (four times per day). It may also be used for the management of corneal and conjunctival abrasions and foreign body injuries, or some cases of chronic blepharitis.\n                  <\/jats:p>","DOI":"10.1111\/j.1475-1313.2006.00416.x","type":"journal-article","created":{"date-parts":[[2006,6,21]],"date-time":"2006-06-21T11:36:48Z","timestamp":1150889808000},"page":"343-361","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fusidic acid viscous eyedrops \u2013 an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists"],"prefix":"10.1007","volume":"26","author":[{"given":"Michael J.","family":"Doughty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon N.","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,6,21]]},"reference":[{"key":"e_1_2_13_2_1","first-page":"317","article-title":"Etude randomis\u00e9e multicentrique acide fusidique gel ophtalmique et rifamycine collyre dans les conjunctivites aigu\u00ebs","volume":"12","author":"Adenis J. P.","year":"1989","journal-title":"J. Fr. Ophtalmol."},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067219600600404"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.suppl_1.5"},{"issue":"1","key":"e_1_2_13_5_1","first-page":"43","article-title":"BSAC standardized disc susceptibility testing method","volume":"48","author":"Andrews J. M.","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_2_13_6_1","unstructured":"Annex D to MLX 273(2002)Proposed prescription only medicines for nurse prescribers(background paper)."},{"key":"e_1_2_13_7_1","first-page":"307","article-title":"Law and Ethics Bulletin: supply of medicinal products to optometrists","volume":"271","author":"Anon","year":"2003","journal-title":"Pharm. J."},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1650-1654.2000"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1998.760121.x"},{"key":"e_1_2_13_10_1","unstructured":"British National Formulary (BNF)(1989)British Medical Association and Royal Pharmaceutical Society of Great Britain Vol.17 pp.346\u2013349."},{"key":"e_1_2_13_11_1","unstructured":"British National Formulary (BNF)(2005)British Medical Association and Royal Pharmaceutical Society of Great Britain Vol.49 pp.521\u2013524."},{"key":"e_1_2_13_12_1","first-page":"389","article-title":"Anaerobic and aerobic bacteriology of acute conjunctivitis","volume":"11","author":"Brook I.","year":"1979","journal-title":"Ann. Ophthalmol. (Chic)."},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(74)80932-4"},{"key":"e_1_2_13_14_1","first-page":"751","article-title":"Quantitative ocular bacteriology. A method for the enumeration and identification of bacteria from the skin\u2010lash margin and conjunctiva","volume":"20","author":"Cagle G. D.","year":"1981","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_13_15_1","first-page":"577","article-title":"Activit\u00e9 de l'acide fusidique sur les bacteries ana\u00e9robies strictes","volume":"35","author":"Canzi A. M.","year":"1987","journal-title":"Path. Biol."},{"key":"e_1_2_13_16_1","first-page":"403","article-title":"Comparison of Fucithalmic (fusidic acid viscous eyedrops 1%) and Chloromycetin Redidrops (chloramphenicol eyedrops 0.5%) in the treatment of acute bacterial conjunctivitis","volume":"1","author":"Carr W. D.","year":"1998","journal-title":"J. Clin. Res."},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00905-X"},{"key":"e_1_2_13_18_1","unstructured":"Chemist and Druggist(2005)POM to P switch for Optrex drops. June 11 pp.36; see also September 10 PriceService."},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.8.2.122"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00073-9"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1987.tb06989.x"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1475-1313.2000.00526.x"},{"key":"e_1_2_13_23_1","first-page":"81","article-title":"A comparison of fusidic acid 1% viscous eyedrops (Fucithalmic, Leo) and Neosporin eye ointment (Wellcome) in patients with external eye infections","volume":"7","author":"Dy\u2010Liacco J. U.","year":"1991","journal-title":"Int. J. Clin. Pract."},{"key":"e_1_2_13_24_1","first-page":"217","article-title":"The effects of fusidic acid and tobramycin in bacterial infections of the conjunctiva and eyelids: a comparative study","volume":"4","author":"El\u2010Shami I.","year":"1989","journal-title":"Saudi Bull. Ophthalmol."},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199507000-00006"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1991.97"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000263125.99262.42"},{"key":"e_1_2_13_28_1","first-page":"623","article-title":"Efficacy of topical antibiotic therapy in acute conjunctivitis in children","volume":"104","author":"Gigliotti F.","year":"1981","journal-title":"J. Pediatr."},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(62)91968-2"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1993.tb00761.x"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjcn.2003.8.8.11566"},{"key":"e_1_2_13_32_1","first-page":"319","article-title":"Laboratory testing for ocular infections","volume":"2","author":"Hampton M. J.","year":"1986","journal-title":"Int. Eye Care"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1978.03910060084018"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00874a034"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200007000-00010"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1993.tb04983.x"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1995.tb00035.x"},{"key":"e_1_2_13_38_1","volume-title":"Pharmaceutical Microbiology","author":"Hugo W. B.","year":"1998"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1987.tb08489.x"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(02)80114-4"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.8.2.125"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004170050300"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1996.tb00087.x"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1046208"},{"key":"e_1_2_13_45_1","first-page":"99","article-title":"Mode of action of antibiotics on various steps of protein synthesis","volume":"1","author":"Kaji A.","year":"1971","journal-title":"Adv. Cytopharmacol."},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120003445"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1992.tb02105.x"},{"key":"e_1_2_13_48_1","first-page":"88","article-title":"Comparative study of fusidic acid and chloramphenicol in bacterial eye infections","volume":"5","author":"Khoury A.","year":"1991","journal-title":"Saudi J. Ophthalmol."},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.06.025"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(65)90721-X"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.suppl_1.17"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1996.tb00092.x"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022521"},{"key":"e_1_2_13_54_1","unstructured":"Medicines Act 1968(1968)Chapter 67.Her Majesty's Stationary Office London."},{"key":"e_1_2_13_55_1","first-page":"15","volume-title":"A Guide for Pharmacists","author":"Medicines, Ethics & Practice","year":"2005"},{"key":"e_1_2_13_56_1","volume-title":"Monthly Index of Medical Specialities (MIMS) for Nurses","author":"MIMS for Nurses","year":"2005"},{"key":"e_1_2_13_57_1","volume-title":"Extended Prescribing of Prescription only Medicines by Independent Nurse Prescribers","author":"MLX 273","year":"2001"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.03.007"},{"key":"e_1_2_13_59_1","unstructured":"Murray L.andEvans R. J.(1992)Comparison of patient acceptability of fusidic acid 1% viscous drops and chloramphenicol 0.5% in the treatment of acute conjunctivitis.Proceeding of the British Association of Accident Emergency(Annual Conf.) 2pages."},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1966.00970050641011"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2002.800212.x"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1986.tb06954.x"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf248"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1157\/13062868"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.1.2.147-149.1975"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1159\/000310878"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38128.631319.AE"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161020-00003"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1987.tb10451.x"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1987.01060070061029"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.7.842"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.66.6.357"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32361-8"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.1.42"},{"key":"e_1_2_13_75_1","first-page":"468","article-title":"A comparison of fusidic acid viscous eyedrops and chloramphenicol eye ointment in acute conjunctivitis","volume":"44","author":"Sinclair N. M.","year":"1988","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(54)90854-5"},{"key":"e_1_2_13_77_1","unstructured":"Statutory Instruments(1977) No. 2127.The Medicines (Prescription Only) Order 1977. Statutory Instrument 1977 No. 2133 MEDICINES The Medicines (Pharmacy and General Sale\u2010Exemption)."},{"key":"e_1_2_13_78_1","unstructured":"Statutory Instruments(1978) No 989MEDICINES The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 1978."},{"key":"e_1_2_13_79_1","unstructured":"Statutory Instruments(1989) No. 1852MEDICINES The Medicines (Prescription Only Pharmacy and General Sale) Amendment Order 1989."},{"key":"e_1_2_13_80_1","unstructured":"Statutory Instruments(1999) No. 3267OPTICIANS The General Optical Council (Rules relating to Injury or Disease of the Eye) Order of Council 1999."},{"key":"e_1_2_13_81_1","unstructured":"Statutory Instrument(2005a) No. 764.MEDICINES. The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2005."},{"key":"e_1_2_13_82_1","unstructured":"Statutory Instrument(2005b) No. 765.MEDICINES. The Medicines for Human Use (Prescribing) Prescribing Order 2005."},{"key":"e_1_2_13_83_1","unstructured":"Statutory Instrument(2005c) No. 766.MEDICINES. The Medicines (Pharmacy and General Sale \u2010 Exemption) Amendment Order 2005."},{"key":"e_1_2_13_84_1","unstructured":"Statutory Instrument(2005d) No. 1476.OPTICIANS. The General Optical Council (Rules relating to Injury or Disease of the Eye and Contact Lens Qualifications) (Amendment) Order of Council 2005."},{"key":"e_1_2_13_85_1","first-page":"1160","article-title":"Laboratory studies in chronic conjunctivitis","volume":"15","author":"Stenson S.","year":"1983","journal-title":"Ann. Ophthalmol. (Chic)."},{"key":"e_1_2_13_86_1","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/aem.57.7.2021-2026.1991","article-title":"D\u2010value determinations are an inappropriate measure of disinfecting activity of common contact lens solutions","volume":"57","author":"Sutton S. W.","year":"1991","journal-title":"Appl. Environ. Microbiol."},{"key":"e_1_2_13_87_1","first-page":"155","article-title":"A critical evaluation of the multi\u2010item microbial challenge test in ophthalmic disinfectant testing","volume":"18","author":"Sutton S. V.","year":"1992","journal-title":"CLAO J."},{"key":"e_1_2_13_88_1","first-page":"39","volume-title":"Proceedings of 3rd Annual Symposium New Developments Ophthalmology","author":"Tabbara K. F.","year":"1986"},{"key":"e_1_2_13_89_1","first-page":"167","article-title":"In vitro susceptibility to fusidic acid of clinically significant isolates from acute ocular infections","volume":"8","author":"Tabbara K. F.","year":"1987","journal-title":"Saudi Med. J."},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(68)90447-6"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.71.8.598"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.72.3.206"},{"key":"e_1_2_13_93_1","first-page":"16","article-title":"The use of chloramphenicol. A discussion of the College guidelines","volume":"210","author":"Taylor S.","year":"1991","journal-title":"Optician"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067219700700102"},{"key":"e_1_2_13_95_1","first-page":"95","article-title":"How new and wider roles for optometrists affect pharmacy","volume":"275","author":"Titcomb L.","year":"2005","journal-title":"Pharm. J."},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00071-5"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27492002000300011"},{"key":"e_1_2_13_98_1","first-page":"371","article-title":"Treatment of blepharitis","volume":"14","author":"Van Bijsterveld O. P.","year":"1988","journal-title":"Acta Ther."},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646112"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189900"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/25.suppl_B.1"},{"key":"e_1_2_13_102_1","first-page":"549","article-title":"Comparison of Fucithalmic (fusidic acid viscous eyedrops 1%) and Noroxin (norfloxacin ophthalmic solution 0.3%) in the treatment of acute bacterial conjunctivitis","volume":"1","author":"Wall A. R.","year":"1998","journal-title":"J. Drug Assess"},{"key":"e_1_2_13_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83479-1"}],"container-title":["Ophthalmic and Physiological Optics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1475-1313.2006.00416.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1475-1313.2006.00416.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:24:34Z","timestamp":1767785074000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1475-1313.2006.00416.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,21]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1111\/j.1475-1313.2006.00416.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1475-1313.2006.00416.x","archive":["Portico"],"relation":{},"ISSN":["0275-5408","1475-1313"],"issn-type":[{"value":"0275-5408","type":"print"},{"value":"1475-1313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,21]]},"assertion":[{"value":"2006-06-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}